HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 243 filers reported holding HORIZON PHARMA PLC in Q4 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $518,000 | +181.5% | 19,606 | +107.7% | 0.01% | +150.0% |
Q4 2018 | $184,000 | +78.6% | 9,438 | +79.5% | 0.00% | +100.0% |
Q3 2018 | $103,000 | -63.1% | 5,259 | -68.7% | 0.00% | -66.7% |
Q2 2018 | $279,000 | +46.8% | 16,821 | +25.9% | 0.00% | +50.0% |
Q1 2018 | $190,000 | -79.7% | 13,358 | -79.2% | 0.00% | -77.8% |
Q4 2017 | $938,000 | -43.7% | 64,237 | -51.1% | 0.01% | -40.0% |
Q3 2017 | $1,667,000 | +53.5% | 131,482 | +43.7% | 0.02% | +50.0% |
Q2 2017 | $1,086,000 | +60.4% | 91,500 | +99.8% | 0.01% | +66.7% |
Q1 2017 | $677,000 | -53.3% | 45,798 | -48.9% | 0.01% | -50.0% |
Q4 2016 | $1,449,000 | +203.1% | 89,543 | +239.3% | 0.01% | +140.0% |
Q3 2016 | $478,000 | +308.5% | 26,390 | +272.8% | 0.01% | +400.0% |
Q2 2016 | $117,000 | -18.2% | 7,078 | -2.0% | 0.00% | 0.0% |
Q3 2015 | $143,000 | -72.9% | 7,220 | -64.4% | 0.00% | -66.7% |
Q1 2015 | $527,000 | +153.4% | 20,274 | +25.9% | 0.00% | +200.0% |
Q4 2014 | $208,000 | +28.4% | 16,109 | +22.2% | 0.00% | 0.0% |
Q3 2014 | $162,000 | – | 13,179 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |